Kayla Harrington, NP
Nurse Practitioner · Hot Springs, ARNPI 1437679164
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,398 of the $6,499 with a category attached, or 83.1%. 36 manufacturers reported payments, led by Medtronic at 31.4% of the total. Reporting peaked in 2022 at $3,285 and has fallen 69.9% since, to $988 in 2025. Among nurse practitioner clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 235 payments — averaging $27.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Axonics, Inc.$1K
- Sumitomo Pharma America, Inc.$542
- AbbVie$322
- 180 Medical, Inc.$224
- Procept Biorobotics Corporation$215
- plus $2K from 30 others
What the payments were for
- Travel & lodging$1,07417%
- Food & beverage$5,39883%
- Education$270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 78 | $2,039 |
| Axonics, Inc. | 21 | $1,478 |
| Sumitomo Pharma America, Inc. | 28 | $542 |
| AbbVie(2 entities) | 17 | $322 |
| 180 Medical, Inc. | 6 | $224 |
| Procept Biorobotics Corporation | 4 | $215 |
| Boston Scientific | 7 | $126 |
| Blue Earth Diagnostics | 6 | $122 |
| Myriad Genetic Laboratories, Inc. | 7 | $118 |
| Coloplast | 6 | $112 |
| Agiliti Surgical, Inc. | 1 | $107 |
| Urovant Sciences Inc | 2 | $99 |
| Myovant Sciences Inc. | 5 | $98 |
| Merck | 4 | $89 |
| Urogen Pharma, Inc. | 3 | $82 |
| Antares Pharma, Inc. | 4 | $77 |
| Endo Pharmaceuticals Inc. | 5 | $75 |
| Olympus America Inc. | 3 | $63 |
| Astellas Pharma US Inc | 4 | $63 |
| Halozyme Inc | 3 | $50 |
| Teleflex LLC | 2 | $41 |
| Photocure Inc | 2 | $41 |
| Ferring Pharmaceuticals Inc. | 2 | $39 |
| Accord Healthcare, Inc. | 2 | $36 |
| Johnson & Johnson | 1 | $34 |
| Pfizer | 2 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Tolmar Pharmaceuticals, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $19 |
| AstraZeneca | 1 | $19 |
| Endo USA, Inc. | 1 | $16 |
| ABC Home Medical Supply, Inc. | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Verity Pharmaceuticals Inc. | 1 | $14 |
| Dendreon Pharmaceuticals LLC | 1 | $14 |
| Angiodynamics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$1,045
- INTERSTIM$686
- AquaBeam Robotic System$151
- Bulkamid$124
- Olympus ShockPulse-SE Lithotripter$107
- GE Healthcare Flex Focus 800 Ultrasound (transducer)$107
- Storz Medical Modulith SLX-F2 ESWL$107
How this compares
$6,499 in reported general payments places this provider in the 95th percentile of 697 nurse practitioner providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 179 | $124,868 |
| GemtesaVibegron | 142 | $100,129 |
| Trospium Chloride | 293 | $16,339 |
| XyostedTestosterone Enanthate | 21 | $15,789 |
| Estradiol | 207 | $13,753 |
| Tamsulosin Hcl | 749 | $10,706 |
| Trimethoprim | 147 | $10,279 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 173 | $6,903 |
| Solifenacin Succinate | 105 | $4,524 |
| Finasteride | 325 | $4,037 |
| Methenamine Hippurate | 30 | $2,998 |
| Potassium Citrate ErPotassium Citrate | 38 | $2,927 |
| Testosterone Cypionate | 41 | $1,281 |
| Nystatin | 67 | $938 |
| Ciprofloxacin Hcl | 112 | $903 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $63 | $124,868179 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $542 | $100,129142 claims |
| Antares Pharma, Inc.Xyosted | $77 | $15,78921 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 697 nurse practitioner providers in Arkansas.
Other nurse practitioner in Hot Springs
- Tiffany McConathyHot Springs$54K
- Virginia LaliberteHot Springs$21K
- Samantha WidemanHot Springs$14K
- Cody WilliamsHot Springs$12K
- Nan MeansHot Springs$7K
- Ragan ArrisonHot Springs$7K
- Laci PattonHot Springs$7K
- Samantha BollanHot Springs$7K
- Mindy FarmerHot Springs$5K
- Kristyl WoolseyHot Springs$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.